Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial
Cohen, Calvin J, Dr, Andrade-Villanueva, Jaime, Prof, Clotet, Bonaventura, MD, Fourie, Jan, MD, Johnson, Margaret A, Prof, Ruxrungtham, Kiat, Prof, Wu, Hao, MD, Zorrilla, Carmen, MD, Crauwels, Herta, PhD, Rimsky, Laurence T, PhD, Vanveggel, Simon, MSc, Boven, Katia, MD
Published in The Lancet (British edition) (16.07.2011)
Published in The Lancet (British edition) (16.07.2011)
Get full text
Journal Article